X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1696) 1696
Paper (684) 684
Patent (559) 559
Publication (475) 475
Report (195) 195
Newspaper Article (118) 118
Conference Proceeding (45) 45
Dissertation (18) 18
Book Chapter (16) 16
Book / eBook (7) 7
Magazine Article (6) 6
Data Set (5) 5
Web Resource (3) 3
Computer File (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (791) 791
experiment (740) 740
cern lhc coll (715) 715
experimental results (708) 708
particle physics (663) 663
high energy physics - experiment (648) 648
physics - high energy physics - experiment (582) 582
p p: scattering (545) 545
cms (544) 544
high energy physics (522) 522
p p: colliding beams (487) 487
13000 gev-cms (364) 364
physics of elementary particles and fields (363) 363
phenomenology (343) 343
chemistry (337) 337
metallurgy (335) 335
particle physics - experiment (268) 268
scattering [p p] (252) 252
hep (232) 232
organic chemistry (229) 229
nuclear experiment (217) 217
8000 gev-cms (213) 213
colliding beams [p p] (213) 213
background (201) 201
hadron-hadron scattering (200) 200
ex (169) 169
compositions based thereon (162) 162
organic macromolecular compounds (162) 162
their preparation or chemical working-up (162) 162
use of inorganic or non-macromolecular organic substances ascompounding ingredients (162) 162
human necessities (155) 155
hygiene (154) 154
medical or veterinary science (154) 154
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (148) 148
humans (148) 148
preparations for medical, dental, or toilet purposes (146) 146
index medicus (142) 142
supersymmetry (117) 117
transverse momentum: missing-energy (114) 114
physics, particles & fields (113) 113
channel cross section: upper limit (107) 107
general tagging of cross-sectional technologies spanning over several sections of the ipc (107) 107
general tagging of new technological developments (107) 107
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (107) 107
heterocyclic compounds (106) 106
cern lab (105) 105
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (100) 100
mass dependence (97) 97
performing operations (97) 97
technologies or applications for mitigation or adaptation againstclimate change (97) 97
transporting (97) 97
compositions of macromolecular compounds (96) 96
final state:jet lepton (95) 95
astrophysics (93) 93
electricity (93) 93
specific therapeutic activity of chemical compounds ormedicinal preparations (93) 93
elementary particles, quantum field theory (92) 92
male (92) 92
quantum field theories, string theory (92) 92
transverse momentum dependence (87) 87
female (84) 84
devices or arrangements related to tyres (83) 83
repairing, or connecting valves to, inflatable elastic bodiesin general (83) 83
tyre changing or repairing (83) 83
tyre inflation (83) 83
vehicle tyres (83) 83
vehicles in general (83) 83
classical and quantum gravitation, relativity theory (80) 80
quantum physics (80) 80
data analysis method (78) 78
top: pair production (77) 77
bottom: particle identification (76) 76
calculating (76) 76
computing (76) 76
counting (76) 76
kinematics (76) 76
high energy astrophysical phenomena (75) 75
jet: bottom (75) 75
rapidity dependence (75) 75
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (70) 70
astronomy & astrophysics (70) 70
z0: leptonic decay (70) 70
channel cross section: branching ratio: upper limit (67) 67
nuclear physics (67) 67
higgs particle: hadroproduction (66) 66
muon: pair production (66) 66
electric digital data processing (62) 62
quantum chromodynamics: perturbation theory (62) 62
final state:jet dilepton (61) 61
114 physical sciences (60) 60
controlling (60) 60
regulating (60) 60
channel cross section: measured (58) 58
instrumentation and detectors (58) 58
jet: transverse momentum (55) 55
mass spectrum: (55) 55
electric communication technique (54) 54
nuclear and high energy physics (54) 54
analysis (53) 53
transverse momentum (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2594) 2594
French (208) 208
German (106) 106
Chinese (52) 52
Spanish (22) 22
Portuguese (18) 18
Japanese (11) 11
Korean (9) 9
Russian (2) 2
Czech (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Indian Journal of Medical Research, ISSN 0971-5916, 08/2015, Volume 142, Issue AUGUST, pp. 139 - 150
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96808
Journal Article
Journal Article
International Journal of Behavioral Nutrition and Physical Activity, ISSN 1479-5868, 02/2014, Volume 11, Issue 1, pp. 26 - 26
Journal Article
Journal Article
Journal of Critical Care, ISSN 0883-9441, 2016, Volume 36, pp. 111 - 115
Journal Article
Molecular Cancer, ISSN 1476-4598, 12/2014, Volume 13, Issue 1, p. 259
Background: Lung cancer is the major cause of cancer-related deaths and many cases of Non Small Cell Lung Cancer (NSCLC), a common type of lung cancer, have... 
Tumor xenograft | NSCLC | PI3K | STAT3 | Targeted therapeutics | EGFR-TKI | mTORC2 | PK-PD | mTORC1 | GEFITINIB | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTITUMOR-ACTIVITY | EGFR | CHEMOTHERAPY | KRAS MUTATIONS | STAT3 ACTIVATION | K-RAS | ONCOLOGY | RESISTANCE | TUMOR-GROWTH | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Proto-Oncogene Proteins p21(ras) | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Activin Receptors, Type II - antagonists & inhibitors | Male | Mechanistic Target of Rapamycin Complex 2 | Quinolines - pharmacology | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | ras Proteins - pharmacology | Phosphatidylinositol 3-Kinases - pharmacology | Antineoplastic Agents - pharmacology | Receptor, Epidermal Growth Factor - pharmacology | Phosphorylation - drug effects | Proto-Oncogene Proteins - pharmacology | Carcinoma, Non-Small-Cell Lung - metabolism | Imidazoles - pharmacology | Animals | Class I Phosphatidylinositol 3-Kinases | Mice, Nude | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | HeLa Cells | Quinazolines - pharmacology | Drug Resistance, Neoplasm - drug effects | Medical equipment and supplies industry | Growth | Health aspects | Medical test kit industry | Mutation | Kinases | Lung cancer | Rodents
Journal Article
Critical Care Medicine, ISSN 0090-3493, 01/2018, Volume 46, Issue 1 Suppl 1, pp. 90 - 90
Journal Article
PLoS ONE, 11/2017, Volume 12, Issue 11
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2017, Volume 35, Issue 31_suppl, pp. 102 - 102
102 Background: Chemotherapy has clinical benefit for elderly patients with careful selection. Selection is based on ECOG Performance Status determination.... 
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2017, Volume 12, Issue 11, p. e0187334
The biology of Hepatitis E Virus (HEV), a common cause of epidemic and sporadic hepatitis, is still being explored. HEV exits liver through bile, a process... 
Usage | Research | Nucleotide sequencing | Liver cells | Endoplasmic reticulum | Hepatitis E virus | DNA sequencing
Journal Article
SAGE Open, ISSN 2158-2440, 6/2011, Volume 1, Issue 1, pp. 1 - 8
The study examines the return and volatility spillover among Asian stock markets in India, Hong Kong, Japan, China, Jakarta, and Korea using a six-variable... 
Multivariate GARCH model | Unit root test | Return and volatility spillovers | Asymmetric volatility response
Journal Article
by Wang, Haidong and Wang, Linhong and Naghavi, Mohsen and Allen, Christine and Barber, Ryan M and Bhutta, Zulfiqar A and Carter, Austin and Casey, Daniel C and Charlson, Fiona J and Chen, Alan Zian and Chen, Wanqing and Coates, Matthew M and Coggeshall, Megan and Dandona, Lalit and Dandona, Rakhi and Dicker, Daniel J and Erskine, Holly E and Ferrari, Alize J and Fitzmaurice, Christina and Foreman, Kyle and Forouzanfar, Mohammad H and Fraser, Maya S and Fullman, Nancy and Gething, Peter W and Goldberg, Ellen M and Graetz, Nicholas and Haagsma, Juanita A and Hay, Simon I and Huynh, Chantal and Huynh, Grace and Johnson, Catherine O and Kassebaum, Nicholas J and Kinfu, Yohannes and Kulikoff, Xie Rachel and Kutz, Michael and Kyu, Hmwe H and Larson, Heidi J and Leung, Janni and Liang, Xiaofeng and Lim, Stephen S and Lind, Margaret and Lozano, Rafael and Marquez, Neal and Mensah, George A and Mikesell, Joe and Mokdad, Ali H and Mooney, Meghan D and Nguyen, Quyen Le and Nguyen, Grant and Nsoesie, Elaine and Pigott, David M and Pinho, Christine and Roth, Gregory A and Salomon, Joshua A and Sandar, Logan and Silpakit, Naris and Sligar, Amber and Sorensen, Reed J D and Stanaway, Jeffrey and Steiner, Caitlyn and Teeple, Stephanie and Thomas, Bernadette A and Troeger, Christopher and VanderZanden, Amelia and Vollset, Stein Emil and Wanga, Valentine and Whiteford, Harvey A and Wolock, Timothy and Zoeckler, Leo and Abate, Kalkidan Hassen and Abbafati, Cristiana and Abbas, Kaja M and Abd-Allah, Foad and Abera, Semaw Ferede and Abreu, Daisy M X and Abu-Raddad, Laith J and Abyu, Gebre Yitayih and Achoki, Tom and Adelekan, Ademola Lukman and Ademi, Zanfina and Adou, Arsène Kouablan and Adsuar, José C and Afanvi, Kossivi Agbelenko and Afshin, Ashkan and Agardh, Emilie Elisabet and Agarwal, Arnav and Agrawal, Anurag and Kiadaliri, Aliasghar Ahmad and Ajala, Oluremi N and Akanda, Ali Shafqat and Akinyemi, Rufus Olusola and Akinyemiju, Tomi F and Akseer, Nadia and Lami, Faris Hasan Al and Alabed, Samer and Al-Aly, Ziyad and Alam, Noore K M and Alam, Khurshid and Alasfoor, Deena and Aldhahri, Saleh Fahed and ... and GBD 015 Mortality and Causes Death and GBD 2015 Mortality and Causes of Death Collaborators and Högskolan Dalarna and Akademin Utbildning, hälsa och samhälle and Medicinsk vetenskap
The Lancet, ISSN 0140-6736, 10/2016, Volume 388, Issue 10053, pp. 1459 - 1544
Journal Article